• News Feeds
Page last updated at 07:49 GMT, Thursday, 2 February 2012

'Frustration' over cancer drug funding

Advertisement

A decision by the drugs watchdog, the National Institute for Health and Clinical Excellence (NICE), to provisionally reject NHS funding for a prostate cancer treatment in England and Wales has been criticised by Cancer Research UK.

Emma Malcolm, chief executive of Prostate Action, told the Today programme's Justin Webb that this is the second prostate cancer drug that has been rejected by NICE and it highlights "health inequalities" in the treatment of male cancers.


Get in touch with Today via email , Twitter or Facebook or text us on 84844.

SEE ALSO

Story Tools

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific